Fresenius Medical Care (FMS) Tops Q2 EPS by 36c

Fresenius Medical Care (NYSE: FMS) reported Q2 EPS of $0.79, $0.36 better than the analyst estimate of $0.43. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $4.13 billion.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT